MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
INM — InMed Pharmaceuticals Inc. Common Shares
NasdaqInMed Pharmaceuticals Inc. Common Shares
$1.33
-0.02(-1.48%)
- O
- 1.37
- H
- 1.39
- L
- 1.33
- V
- 28.33K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About INM
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 10, 2020
Employees6
Stock ExchangeNasdaq
Ticker SymbolINM
Websitehttps://www.inmedpharma.com
Key Financial Statistics
| Market Cap | $7.31M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.57 - $2.50 |
| 52-Week Avg Volume | 764.5K |
| VWAP | $1.33 |
| Transactions | 108 |
| Total Recorded Bars | 3,122 days |